Lotti VJ - Search Results

1

In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.

Chang RS, Siegl PK, Clineschmidt BV, Mantlo NB, Chakravarty PK, Greenlee WJ, Patchett AA, Lotti VJ. Chang RS, et al. Among authors: lotti vj. J Pharmacol Exp Ther. 1992 Jul;262(1):133-8. J Pharmacol Exp Ther. 1992. PMID: 1625192

2

In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.

Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ. Siegl PK, et al. Among authors: lotti vj. J Pharmacol Exp Ther. 1992 Jul;262(1):139-44. J Pharmacol Exp Ther. 1992. PMID: 1625193

3

Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.

Mantlo NB, Chakravarty PK, Ondeyka DL, Siegl PK, Chang RS, Lotti VJ, Faust KA, Chen TB, Schorn TW, Sweet CS, et al. Mantlo NB, et al. Among authors: lotti vj. J Med Chem. 1991 Sep;34(9):2919-22. doi: 10.1021/jm00113a035. J Med Chem. 1991. PMID: 1895308 No abstract available.

4

Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency.

Chang RS, Lotti VJ. Chang RS, et al. Among authors: lotti vj. Life Sci. 1991;49(20):1485-90. doi: 10.1016/0024-3205(91)90048-g. Life Sci. 1991. PMID: 1943452

5

Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.

Chang RS, Lotti VJ. Chang RS, et al. Among authors: lotti vj. Mol Pharmacol. 1990 Mar;37(3):347-51. Mol Pharmacol. 1990. PMID: 2314387

6

Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonists.

Chang RS, Lotti VJ, Chen TB, Faust KA. Chang RS, et al. Among authors: lotti vj. Biochem Biophys Res Commun. 1990 Sep 14;171(2):813-7. doi: 10.1016/0006-291x(90)91218-h. Biochem Biophys Res Commun. 1990. PMID: 2403363

7

In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.

Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RS, Clineschmidt BV. Lotti VJ, et al. J Pharmacol Exp Ther. 1987 Apr;241(1):103-9. J Pharmacol Exp Ther. 1987. PMID: 2437282

8

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.

Lotti VJ, Chang RS. Lotti VJ, et al. Eur J Pharmacol. 1989 Mar 21;162(2):273-80. doi: 10.1016/0014-2999(89)90290-2. Eur J Pharmacol. 1989. PMID: 2721567

9

Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.

Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ. Chang RS, et al. Among authors: lotti vj. Mol Pharmacol. 1989 Jun;35(6):803-8. Mol Pharmacol. 1989. PMID: 2733696

10

A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.

Clineschmidt BV, Pettibone DJ, Lotti VJ, Hucker HB, Sweeney BM, Reiss DR, Lis EV, Huff JR, Vacca J. Clineschmidt BV, et al. Among authors: lotti vj. J Pharmacol Exp Ther. 1988 Apr;245(1):32-40. J Pharmacol Exp Ther. 1988. PMID: 2896239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters